Cancer Prevention Vaccination

HPV Vaccine in Nepal — Gardasil 9 & Cervical Cancer Prevention 9-valent HPV vaccination protecting against cervical cancer and genital warts

The HPV vaccine in Nepal — Gardasil 9 — protects against the human papillomavirus types responsible for most cervical cancers and genital warts. Learn about schedule, eligibility, effectiveness, and availability in Kathmandu.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

Important Safety Information

  • Complete the full vaccine series — partial vaccination provides incomplete protection.
  • Vaccination does not replace cervical cancer screening — Pap smears remain essential.
  • Pregnant women should defer vaccination until after delivery.
  • Severe allergic reaction to previous vaccine dose is a contraindication.
  • The vaccine prevents future infection but does not treat existing HPV or cervical abnormalities.

HPV Vaccination in Kathmandu and Nepal

  • Cervical cancer burden — Cervical cancer is among the leading causes of cancer death among Nepali women; HPV vaccination is a critical prevention strategy.
  • Government program — Nepal Ministry of Health and Population has introduced HPV vaccination in some districts; private availability in Kathmandu provides broader access.
  • School-based programs — HPV vaccination is being integrated into adolescent health programs; private vaccination complements school-based efforts.
  • Cultural considerations — Discussion of HPV and cervical cancer may face cultural barriers; education and confidential services help overcome stigma.
  • Cost accessibility — HPV vaccine costs in Kathmandu vary; private vaccination provides access for those outside government program coverage.
  • Screening integration — Vaccination complements but does not replace cervical cancer screening — Pap smears remain essential.

HPV Vaccine: Preventing Cervical Cancer

The human papillomavirus (HPV) is the most common sexually transmitted infection globally — most sexually active people acquire it at some point. While most infections clear naturally, persistent infection with high-risk HPV types causes cervical cancer, which remains a leading cause of cancer death among women worldwide, including in Nepal. The HPV vaccine prevents infection with the virus types most responsible for cancer and genital warts.

Gardasil 9, the current 9-valent HPV vaccine, protects against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Types 16 and 18 cause approximately 70 percent of cervical cancers; types 6 and 11 cause approximately 90 percent of genital warts; the additional five types account for most remaining cervical cancer cases. The vaccine is highly effective when administered before exposure to these types.

The vaccine is most effective when given before sexual debut — ideally between ages 9 and 14 — but provides benefit for older adolescents and adults who may not yet have been exposed to all vaccine types. Vaccination does not replace cervical cancer screening — regular Pap smears or HPV testing remain essential even for vaccinated women.

This guide explains HPV vaccine types, schedule, effectiveness, eligibility, cost in Nepal, availability in Kathmandu, and the importance of combining vaccination with regular cervical screening.

What Is the HPV Vaccine and How Does It Work?

The HPV vaccine is a recombinant protein vaccine that contains virus-like particles (VLPs) mimicking the outer shell of HPV types covered by the vaccine. These VLPs cannot cause infection — they trigger the immune system to produce antibodies that neutralise the real virus if exposed later.

Gardasil 9 protects against nine HPV types: low-risk types 6 and 11 (genital warts) and high-risk types 16, 18, 31, 33, 45, 52, and 58 (cervical, anal, oropharyngeal, and other cancers). By preventing infection with these types, the vaccine dramatically reduces cancer risk.

The vaccine does NOT treat existing HPV infection or cervical abnormalities — it is preventive only. Vaccinated individuals still need regular cervical cancer screening. The vaccine does not protect against all HPV types or other STIs — condoms and regular screening remain important.

  • Recombinant vaccine with virus-like particles — cannot cause infection.
  • Gardasil 9 covers 9 HPV types: 6, 11, 16, 18, 31, 33, 45, 52, 58.
  • Prevents ~70% cervical cancer (types 16/18) and ~90% genital warts (types 6/11).
  • Prevention only — does not treat existing infection or abnormalities.
  • Does not replace cervical screening — Pap smears still essential.

How It Works

Virus-like particles trigger antibody production without causing infection.

9-Valent Coverage

Protects against 9 HPV types responsible for most cancers and genital warts.

Cancer Prevention

Prevents ~70% of cervical cancers and other HPV-related cancers.

Prevention Not Treatment

Vaccination prevents future infection — does not treat existing HPV or abnormalities.

Schedule, Eligibility, and Effectiveness

The HPV vaccine is given as a series of 2 or 3 intramuscular injections, depending on age at first dose. For ages 9 to 14, two doses are recommended — the second dose 6 to 12 months after the first. For ages 15 and older, three doses are recommended — at 0, 1–2, and 6 months.

The vaccine is most effective when administered before sexual debut — ideally before any HPV exposure. However, it provides benefit for older adolescents and adults up to age 45 who may not yet have been exposed to all vaccine types. Prior HPV infection or vaccination does not necessarily preclude vaccination.

Effectiveness is highest when the full series is completed on schedule. Studies show near-100% protection against vaccine-type HPV infections in individuals vaccinated before exposure. Protection appears long-lasting, with follow-up studies showing sustained immunity for over 10 years.

  • Ages 9–14: 2 doses, second dose 6–12 months after first.
  • Ages 15+: 3 doses at 0, 1–2, and 6 months.
  • Most effective before sexual debut — but beneficial for older individuals.
  • Available up to age 45 for those not previously vaccinated.
  • Near-100% protection against vaccine types when completed before exposure.

2-Dose Schedule

Ages 9–14: two doses 6–12 months apart — simpler and equally effective.

3-Dose Schedule

Ages 15+: three doses at 0, 1–2, and 6 months for optimal protection.

Best Timing

Before sexual debut provides maximum benefit — but older vaccination still helps.

Long-Lasting Protection

Sustained immunity demonstrated for over 10 years in follow-up studies.

Who Should Get the HPV Vaccine?

Routine HPV vaccination is recommended for all adolescents — boys and girls — at ages 11 to 12, though vaccination can start as early as age 9. Vaccinating both sexes protects against genital warts, anal, oropharyngeal, and other cancers, and reduces overall HPV transmission in the community.

Catch-up vaccination is recommended for females up to age 26 and males up to age 21 who were not previously vaccinated. Shared clinical decision-making for vaccination extends to age 45 for those not adequately vaccinated — discussing individual risk and benefit with a clinician.

Specific populations benefit particularly: immunocompromised individuals (HIV-positive, transplant recipients, those on immunosuppressants) who may have reduced vaccine response and higher HPV-related cancer risk; people with prior HPV-related disease or precancerous lesions; and those with multiple partners or new relationships.

  • Routine: all adolescents 11–12 (can start at 9), both boys and girls.
  • Catch-up: females to 26, males to 21 if not previously vaccinated.
  • Shared decision to age 45 for those not adequately vaccinated.
  • Immunocompromised: HIV+, transplant, immunosuppressants — higher benefit.
  • Prior HPV disease or precancerous lesions — vaccination still beneficial.

Routine Vaccination

All adolescents 11–12 regardless of sex — protects against cancer and warts.

Catch-Up Ages

Females to 26, males to 21 — vaccination still beneficial if missed earlier.

Through Age 45

Shared decision-making for adults 27–45 based on individual risk.

Special Populations

Immunocompromised and those with prior HPV disease benefit significantly.

Safety, Side Effects, and Common Questions

The HPV vaccine has an excellent safety profile backed by extensive global monitoring. Common side effects are mild and temporary — pain, redness, or swelling at the injection site; mild headache, fatigue, or muscle aches. Serious adverse events are extremely rare. The vaccine does not cause HPV infection, cancer, or fertility problems.

Common myths include beliefs that the vaccine causes infertility, promotes sexual activity, or is only for women. The vaccine is recommended for both boys and girls, does not affect fertility, and does not encourage sexual behaviour — it prevents cancer-causing infections regardless of when sexual activity begins.

Pregnant women should defer vaccination until after delivery, though inadvertent vaccination during pregnancy is not associated with adverse outcomes. Breastfeeding women can be vaccinated. The vaccine can be given with other vaccines — including COVID-19 and other routine immunisations.

  • Excellent safety profile — extensive global monitoring confirms safety.
  • Common side effects: injection site pain, mild headache, fatigue — temporary.
  • Does NOT cause HPV infection, cancer, or fertility problems.
  • For both boys and girls — not just women.
  • Pregnant women defer until after delivery; breastfeeding OK.

Proven Safety

Extensive monitoring confirms excellent safety profile — serious events extremely rare.

Mild Side Effects

Injection site reactions and mild systemic symptoms — temporary and self-limiting.

Myth Correction

Does not cause infertility, promote sexual activity, or only protect women.

Pregnancy Guidance

Defer during pregnancy; safe while breastfeeding; compatible with other vaccines.

HPV Vaccination Services and Pricing

ServiceWhat It IncludesCost (NPR)
HPV Vaccine (Gardasil 9) — Dose 1First dose of 9-valent HPV vaccine.Rs. 6,000–10,000
HPV Vaccine — Dose 2Second dose (6–12 months after first for ages 9–14).Rs. 6,000–10,000
HPV Vaccine — Dose 3Third dose (for ages 15+ at 0, 1–2, 6 months).Rs. 6,000–10,000
HPV Vaccination ConsultationAssessment of eligibility, schedule, and catch-up planning.Rs. 450–700
Cervical Cancer Screening (Pap Smear)Cervical cytology for cancer screening — recommended regardless of vaccination.Rs. 1,500–3,000
HPV DNA TestingHPV genotyping for cervical cancer risk assessment.Rs. 3,000–6,000
Vaccination Record & CertificateDocumentation of vaccination for school/employment requirements.Included

Prices are indicative; confirm current availability and rates when booking.

Why Choose Thamel Clinic for HPV Vaccination

  • Gardasil 9 availability — 9-valent vaccine protecting against most cancer-causing and wart-causing types.
  • All ages welcome — Routine adolescent vaccination plus catch-up through age 45.
  • Both sexes — Vaccination for boys and girls, not just females.
  • Screening integration — Pap smears and HPV testing alongside vaccination for comprehensive care.
  • Transparent pricing — Clear per-dose costs with package options available.
  • Certified administration — Trained staff administering vaccines with proper cold chain management.
  • Educational support — Counselling on vaccine benefits, schedule, and cervical screening importance.

Frequently Asked Questions

What does the HPV vaccine protect against?

Gardasil 9 protects against 9 HPV types — preventing approximately 70% of cervical cancers, 90% of genital warts, and other HPV-related cancers including anal and oropharyngeal cancers.

At what age should HPV vaccination start?

Routine vaccination is recommended at ages 11–12, though it can start as early as age 9. Two doses suffice for ages 9–14; three doses for ages 15 and older.

Is the HPV vaccine only for girls?

No — HPV vaccination is recommended for both boys and girls. It prevents cervical cancer in females and genital warts, anal, and oropharyngeal cancers in both sexes.

How many doses of HPV vaccine are needed?

Ages 9–14 need 2 doses 6–12 months apart. Ages 15 and older need 3 doses at 0, 1–2, and 6 months. Completing the full series is essential for optimal protection.

Is the HPV vaccine safe?

Yes — the HPV vaccine has an excellent safety profile confirmed by extensive global monitoring. Side effects are typically mild: injection site pain, headache, fatigue. Serious adverse events are extremely rare.

Does the HPV vaccine cause infertility?

No — extensive research confirms the HPV vaccine does not affect fertility. This is a common myth not supported by evidence.

Do I still need cervical screening after vaccination?

Yes — vaccination does not protect against all cancer-causing HPV types or treat existing infection. Regular Pap smears or HPV testing remain essential for cervical cancer prevention.

How much does the HPV vaccine cost in Nepal?

Each dose typically costs Rs. 6,000–10,000, so the full series ranges Rs. 12,000–30,000 depending on age and schedule. Consultation and screening costs are additional.

Can I get the HPV vaccine if I am already sexually active?

Yes — vaccination is still beneficial if you have not been exposed to all vaccine-covered HPV types. However, it is most effective before sexual debut. Discuss your individual situation with a clinician.

Is the HPV vaccine available in Kathmandu?

Yes — Gardasil 9 is available at Thamel Clinic and other private facilities in Kathmandu. Government programs are also expanding availability in some districts.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Vaccination and preventive health reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current WHO and CDC guidance. This is general medical information; a registered clinician must assess each patient before treatment.

View clinic team and credentials

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 7, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now